BMS 493Cat. No. 3509 |
Price and AvailabilityBy clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy. |
|
Chemical Name: 4-[(1E)-2-[5,6-Dihydro-5,5-dimethyl-8-(2-phenylethynyl)-2-naphthalenyl]ethenyl]benzoic acid |
Biological Activity
Pan-retinoic acid receptor (pan-RAR) inverse agonist. Enhances nuclear corepressor (NCoR) interaction with RARs. Binding induces analogous conformational changes in all RAR types (RARα, RARβ and RARγ).Certificate of Analysis / Safety Data Sheet
References
Rinkevich et al (2007) Systemic bud induction and retinioic acid signaling underlie whole body regeneration in the urochordate Botrylloides leachi. PLoS Biology. 5 e71. PMID: 17341137.
Germain et al (2009) Differential action on coregulator interaction defines retinoid agonists and neutral antagonists. Chem.Biol. 16 479. PMID: 19477412.
If you know of a relevant citation for this product please let us know.
View Related Products by Target
Keywords: BMS 493, supplier, BMS493, retinoic, acid, receptors, agonists, RAR, agonists, inverse, pan-RAR
Quick Order
Find multiple products by catalog number
New Products in this Area
Synthetic progesterone analog
GC 1High affinity thyroid receptor α (TRα) and TRβ agonist; thyromimetic
SR 8278REV-ERBα antagonist
TCPOBOPConstitutive androstane receptor (CAR) agonist
20% Discount*
Potent, selective LRRK2 inhibitor
Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.





